Back to Agenda
Session 5, Track B: Optimizing Clinical Trials Operationally in Canada
Session Chair(s)
Marie-France Goyer, MSC
Senior Director, Clinical Operations, Abcellera, Canada
Émilie Lévesque, MSC
Senior Clinical Quality Manager, Abcellera, Canada
Lorella Garofalo, PHD
Head of Regulatory Sciences, Pfizer Canada ULC, Canada
There is currently high interest by Canadian stakeholders, including government, to strengthen the clinical trials ecosystem in Canada. This presents a unique opportunity to further evolve and grow medical innovation as well as support patient care through clinical research. At the same time, there are new challenges in this sector. This session will provide an overview of ongoing initiatives as well as resources available for clinical research professionals and organizations to respond to opportunities and challenges as well as to maximize the success of their clinical research efforts.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify challenges related to advancing clinical research in Canada
- Recognize the resources available to support various aspects of clinical research
Speaker(s)
Rebecca Barnes, MS
Executive Director, Network of Networks (N2), Canada
Supporting Canadian Clinical Research Excellence Through Collaboration
Bruno J Battistini, PHD, MSC
Adjunct-Professor & Lecturer, Faculty of Health Sciences, University of Ottawa, Canada
Speaker
Sven Ansorge, PHD
Associate Director of Technical Training, CASTL Canada, Canada
Introduction to Biopharmaceutical Manufacturing
Have an account?